Could the world have a coronavirus immunization by September? Kumar Jeetendra | April 28, 2020 A coronavirus immunization is one bit nearer because of promising outcomes following testing on monkeys – with across the board accessibility to conceivably come as ahead of schedule as September. Six rhesus macaque monkeys were infused with a portion of the Oxford University researchers’ antibody and remain contamination free a month subsequent to being presented …
U.S. FDA favors GSK unit’s medication to treat newborn children and kids with HIV Kumar Jeetendra | June 13, 2020 The U.S. Food and Drug Administration has endorsed a medication to treat newborn children and kids with HIV, with the medication having been created by drugmaker GlaxoSmithKline’s HIV drugs division ViiV Healthcare, the FDA and the GSK unit said. The FDA said on Friday it was conceding Viiv the endorsement of Tivicay and Tivicay PD …
GSK in mission to be ideal, not first, in race for COVID-19 antibody Kumar Jeetendra | June 20, 2020 There is a prominent name missing from the leaders in the race to test exploratory immunisations against the novel coronavirus: the world’s biggest antibody producer GlaxoSmithKline . What’s more, that is totally fine as indicated by the British gathering’s main clinical official for antibodies Thomas Breuer, who says the organization inclines toward the gradual methodology …
Protein-based COVID-19 vaccine trial launched by Sanofi and GSK Kumar Jeetendra | September 3, 2020 French drugmaker Sanofi and its British peer GSK have begun a clinical trial for a protein-based COVID-19 vaccine candidate, as pharmaceutical firms race to develop treatments against the coronavirus pandemic. Sanofi and GSK said in a joint statement on Thursday they’d begun the”Stage 1/2″ trial for their adjuvanted COVID-19 vaccine, and that they expect to …
